陈明坤，男，医学博士，主治医师。2002-2013年先后就读于中国医科大学、中山大学
肿瘤防治中心、中山大学附属第三医院，获医学博士学位。擅长前列腺癌、前列腺增生及前列腺炎的个体化治疗（适时药物干预、微创手术及手术后功能康复），同时兼治泌尿系结石、精索静脉曲张等疾病的微创治疗。至今以第一作者在相关领域发表SCI论文6篇。主持广东省自然科学基金1项，南方医科大学优秀青年科研人员启动项目1项，参与完成多项国家自然基金项目。科研成果：1、CHEN MK, LUO Y, ZHANG, H et al. Laparoscopic radical prostatectomy plus extended lymph nodes dissection for cases with non-extra node metastatic prostate cancer: 5-year experience in a single Chinese institution. J Cancer Res Clin Oncol. 2013 139: 871C878. (IF: 2.93)2、CHEN MK, QIN ZK, ZHOU FJ et al. Intra-arterial Chemotherapy Is Reliable in Preventing High-risk Superficial Bladder Cancer from Recurrence and Progression. Journal of Chemotherapy. 2009, 21(6): 681-686. (IF:1.2)3、CHEN MK, Luo Y, Zhang H, et al. Investigation of optimal prostate biopsy schemes for Chinese patients with different clinical characteristics. Urol Int. 2012 89(4): 425-432. (IF:1.0)4、CHEN MK, YE YL, ZHOU FJ et al. Clipping the extremity of ureter prior to nephroureterectomy is effective for preventing subsequent bladder recurrence after upper urinary tract urothelial carcinoma. Chin Med J (Engl). 2012 Nov;125(21): 3821-6 (IF:0.98)5、LI K*, CHEN MK* (co-first author), Si-Tu Jie, et al. The role of co-expression of c-Myc, EZH2 and p27 in prognosis of prostate cancer patients after surgery. Chin Med J (Engl). 2013 Jan; 2013(1): 82-87. (IF:0.98)6、LI K*, CHEN MK*(co-first author), SITU Jie et al. The predictive value of semaphorins 3 expression in biopsies for biochemical recurrence of patients with low- and intermediate prostate cancer risk. Neoplasma. 2013 60(6). (IF: 1.56)7、XIONG D*, YE YL*, CHEN MK, et al. Non-muscle myosin II is an independent predictor of overall survival for cystectomy candidates with early-stage bladder cancer. Oncol Rep. 2012 Nov; 28(5):1625-1632. (IF: 1.85)
